| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S7919 R24018 |
Sjaarda, 2020 | Pregnancy loss (any loss occurring after hCG detection of pregnancy) | early pregnancy | prospective cohort | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: no or not specified | 1.11 [0.75;1.66] | 16/75 143/662 | 159 | 75 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S493 R15258 |
Colvin, 2011 | Terminations of Pregnancy (both spontaneous abortions and elective) | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 1.26 [0.91;1.37] | 867/3,565 24,313/119,840 | 25,180 | 3,565 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5958 R25442 |
Diav-Citrin - Fluoxetine or Paroxetine, 2008 | Intrauterine death (ETOP, Miscarriage, stillbirth, ectopic) | during pregnancy (anytime or not specified) | prospective cohort | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 1.82 [1.42;2.33] C | 138/809 149/1,467 | 287 | 809 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S15011 R61499 |
Lennestal, 2007 | Intrauterine Deaths | early pregnancy | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: no or not specified | 1.70 [0.60;3.60] | 6/- 3,197/- | 3,203 | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S510 R15162 |
Casper, 2003 | Miscarriages | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) | 0.35 [0.09;1.34] C | 9/31 7/13 | 16 | 31 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 5 studies | 1.33 [0.99;1.79] | 28,845 | 4,480 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asymetry test p-value = 0.5020 (by Egger's regression)
slope=0.4915 (0.2478); intercept=-1.1467 (1.5067); t=0.7610; p=0.5020
excluded